Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects

Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects

Conditions: Diabetes Mellitus, Type 2
Interventions: Drug: Dapagliflozin; Drug: Placebo
Sponsors: The University of Texas Health Science Center at San Antonio; AstraZeneca
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 5, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments